NewsCANCER LETTERSSunday, March 15, 2026 · March 15, 2026
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies.
WHY IT MATTERS
Recent peer-reviewed research on Small cell lung cancer that may be relevant for patients and caregivers.
Small cell lung cancer (SCLC) is characterized by rapid progression, early metastasis, and poor prognosis, with a five-year survival rate of less than 7%. In recent years, advances in immunotherapy, particularly the application of immune checkpoint inhibitors (ICIs) have transformed the treatment la...
Related conditions
Related news
Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.…
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.…
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.…
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.…